Stock listing

NASDAQ:ACOR Acorda Therapeutics Inc Stock

Follow Acorda Therapeutics Inc into a list and get an email when it puts out news.

Delisted NASDAQ:ACOR no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ACOR
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Acorda Therapeutics Inc on 6ix

Calls
10 calls with a replay · 10 with a transcript · latest Nov 13, 2023
Decks
5 decks · latest Nov 13, 2023

Where Acorda Therapeutics Inc is listed

ListingExchangeCountryCurrency
NASDAQ:ACOR · This page · DelistedNASDAQUnited StatesUSD
OTC:ACORQ · DelistedOTCUnited StatesUSD

Events

CallWhenStatus
Acorda Therapeutics (ACOR) Q3 2023 Earnings CallMon, Nov 13, 2023 · 4:30 PM ETReplay
Acorda Therapeutics (ACOR) Q2 2023 Earnings CallTue, Aug 08, 2023 · 4:30 PM ETReplay
Acorda Therapeutics (ACOR) Q1 2023 Earnings CallThu, May 11, 2023 · 4:30 PM ETReplay
Acorda Therapeutics (ACOR) Q4 2022 Earnings CallThu, Mar 09, 2023 · 8:30 AM ETReplay
Acorda Therapeutics (ACOR) Q3 2022 Earnings CallTue, Nov 01, 2022 · 4:30 PM ETReplay
Acorda Therapeutics (ACOR) Q2 2022 Earnings CallThu, Aug 04, 2022 · 4:30 PM ETReplay
Acorda Therapeutics (ACOR) Q1 2022 Earnings CallWed, May 11, 2022 · 4:30 PM ETReplay
Acorda Therapeutics (ACOR) Q4 2021 Earnings CallWed, Mar 09, 2022 · 4:30 PM ETReplay
Acorda Therapeutics (ACOR) Q3 2021 Earnings CallTue, Nov 09, 2021 · 4:30 PM ETReplay
Acorda Therapeutics (ACOR) Q2 2021 Earnings CallThu, Aug 05, 2021 · 4:30 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Q3 2023 Earnings PresentationEarnings19 slidesNov 13, 2023
Q2 2023 Earnings PresentationEarnings20 slidesAug 8, 2023
Q1 2023 Earnings PresentationEarnings20 slidesMay 11, 2023
Q4 2022 Earnings PresentationEarnings20 slidesMar 9, 2023
Q3 2022 Earnings PresentationEarnings25 slidesNov 1, 2022

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Burkhard Blank
Other companies: MannKind Corporation (EVP Chief Medical Officer · Since at least May 24, 2023)
CMO and Head of R&D · Jul 1, 2016 – Mar 3, 2021 · Past
Enrique J Carrazana
Other companies: Marinus Pharmaceuticals Inc (Director · Jul 31, 2014 – Jan 15, 2021 · Past)
Chief Medical Officer · Dec 15, 2011 – Dec 1, 2015 · Past
Kerry Clem
Other companies: OS Therapies Incorporated (Chief Commercial Officer · Since at least Oct 1, 2026)
Chief Commercial Officer · Sep 9, 2021 – Mar 31, 2023 · Past
Standish Fleming
Other companies: Ambit Biosciences Corp (Director · May 15, 2013 – May 15, 2014 · Past)
Director · Feb 9, 2006 – Feb 15, 2006 · Past
Andrew BlightChief Scientific Officer · Jul 19, 2013 – Mar 1, 2017 · Past
Catherine D StraderDirector · Feb 17, 2017 – Jun 2, 2021 · Past
Michael A GesserChief Financial Officer · Nov 8, 2021 – Nov 8, 2021 · Past
Peder JensenDirector · Jun 10, 2022 – Jun 22, 2023 · Past
Sandra Phd PanemDirector · Jun 19, 2019 – Jun 22, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Acorda Therapeutics Inc.